Search Results

Priya Life Science joins as an official Media Partner for Fleming Events' 9th Annual Corporate Compliance & Transparency in Life Sciences Summit, taking place November 17-18, 2026 in Zurich, Switzerland. Includes an exclusive 20% registration discount code (corporate20) for our readers.

Ireland built a life-science powerhouse by being the easiest place in Europe for global talent to land and stay. The proposed move from five to eight years for citizenship changes the terms on which the sector's skilled workforce agreed to come here. This analysis looks at what it means for engineers and scientists on Critical Skills permits, for the companies that depend on them, and what a fairer Bill would look like.

The Government wants to raise the residency requirement for Irish citizenship from five years to eight, with language and civics tests on top. This analysis looks at who actually carries the weight of that change: the internationally trained nurses, care assistants and pharmaceutical professionals who keep Irish hospitals, nursing homes and manufacturing plants running, and how Ireland would compare with Canada, Australia and the rest of Europe.

As the EU AI Act, updated EFPIA codes, and multi-jurisdictional enforcement reshape life sciences, the 9th Annual Corporate Compliance & Transparency in Life Sciences Conference in Zurich sets the critical 2027 benchmark for Irish biopharma leaders.

Building on Sreedevi Vijayakumari's analysis of Ireland's infrastructure overruns, this article examines how digital project management practices close the operational delivery gaps behind scope creep, slipped milestones, and portfolio blind spots across public works and life sciences.

Securing market entry in Europe requires navigating the centralized EMA regulatory approval and country-specific pricing and reimbursement frameworks. This handbook outlines key steps under the new EU HTAR.

SK pharmteco has finalized a major manufacturing expansion at its Swords site in Co. Dublin, Ireland. The project adds a multipurpose GMP small-molecule API facility and a kilo-scale GMP HPAPI and ADC payload facility to scale potent therapies from development to commercial supply.

The University of Galway has been chosen to lead the new €64.5 million Research Ireland Rinn Medical Devices Centre as part of a landmark €460 million government investment in seven new national Rinn research centres.

Ireland's contract manufacturing exports-colloquially known as "phantom exports"-are surging once again, raising fresh questions about the decoupling of headline economic figures from the domestic life sciences economy.

An in-depth analysis of how US Most Favored Nation (MFN) drug pricing proposals and the Inflation Reduction Act (IRA) are forcing pharmaceutical companies to restructure indication sequencing, ex-US launches, and global supply chains.

An expert analysis of the strategic shifts required in global drug development, indication sequencing, and launch timelines in response to proposed Most Favored Nation pricing and the Inflation Reduction Act.